Tag: Orphan Drug Act

A total of 25 posts are filed under Orphan Drug Act
BioPharma Dive: 5 Trends Shaping Rare Disease Drug Development
Story by Ned Pagliarulo Amid ongoing scrutiny of rising prescription drug costs, a three decade-old law has become a new flash point in the… Continue Reading
Rare Disease Report: Making Progress in Rare Diseases
After 30 years, the Orphan Drug Act is helping small companies innovate in small patient populations. While rare diseases are, by… Continue Reading
RARECast: Rare Disease Legislation Advancing at National, State Level
    The 21st Century Cures Act, an ambitious piece of legislation of great concern to the rare disease community, passed the House last… Continue Reading
RARECast: The Evolving Relationship Between Patient Advocates and Pharma
  As pharmaceutical companies, spurred by the Orphan Drug Act, have delved deeper into the development of drugs to treat rare diseases,… Continue Reading
Why Rare Disease Research Should Matter to Everyone
Rare disease research may focus on individual diseases that affect small patient populations, but often the information gleaned from this… Continue Reading
RARECast: Researchers Say Reform of the Orphan Drug Act is Needed
The Orphan Drug Act has provided critical incentives that have helped fuel the development of scores of drugs to treat rare diseases. But… Continue Reading
RAREcast: How the Orphan Drug Act Reshaped the Rare Disease Landscape
The U.S. Food and Drug Administration approved more than 230 new drugs to treat rare diseases in the past decade and there are currently… Continue Reading

Follow us on Twitter